Optic atrophy due to Moya Moya disease in Trisomy 21

<h3></h3> A 38-year-old woman with trisomy 21 presented with unilateral optic nerve atrophy due to Moyamoya Disease (MMD). She had a narrow palate, epicanthal folds and moderate developmental delay. Her past ocular history was normal. Her mother noted a change in visual behavior. Neuro-ophthalmic examination showed a visual acuity of 20/80 OD and 20/25 OS and a relative afferent pupillary defect OD. The patient could not perform automated perimetry. Slit lamp biomicroscopy showed Brushfield spots OU. Ophthalmoscopy showed diffuse optic atrophy OD and a normal optic nerve OS. Testing including serum B12 and B9 levels, syphilis serology, tuberculosis IGRA, and chest radiography were negative. MRI with contrast showed chronic lacunar infarcts in the periventricular white matter and absence of the left internal carotid artery (ICA) flow void likely due to occlusion. The right optic nerve was atrophic with increased T2 signal. CTA with contrast showed chronic occlusion of the left ICA, right posterior cerebral artery, right middle cerebral artery and left anterior cerebral artery A2 segment with extensive collateralization. Severe narrowing of the proximal left ICA beginning 5 mm beyond the bifurcation was noted. A catheter cerebral angiogram confirmed MMD. Vascular neurology and neurosurgery were consulted. Aspirin 81 mg daily was started. Moyamoya angiopathy is rare, optic atrophy is an unconventional presentation and they can be associated with trisomy 21. Studies are warranted to better understand and treat this condition.

Authors

Institutions

Publication Details

Published
2024-11-01
DOI
https://doi.org/10.1136/jnnp-2024-abn.265
Primary Topic
Moyamoya disease diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optic atrophy due to Moya Moya disease in Trisomy 21

Laila Noor, Susana d'Avila, Ahmed Osama, A.S. Al-Deen et al.
Moyamoya disease diagnosis and treatment
article

Optic atrophy due to Moya Moya disease in Trisomy 21

Laila Noor, Susana d'Avila, Ahmed Osama, A.S. Al-Deen, Mbydeen Tsneem HS
article en

Abstract

<h3></h3> A 38-year-old woman with trisomy 21 presented with unilateral optic nerve atrophy due to Moyamoya Disease (MMD). She had a narrow palate, epicanthal folds and moderate developmental delay. Her past ocular history was normal. Her mother noted a change in visual behavior. Neuro-ophthalmic examination showed a visual acuity of 20/80 OD and 20/25 OS and a relative afferent pupillary defect OD. The patient could not perform automated perimetry. Slit lamp biomicroscopy showed Brushfield spots OU. Ophthalmoscopy showed diffuse optic atrophy OD and a normal optic nerve OS. Testing including serum B12 and B9 levels, syphilis serology, tuberculosis IGRA, and chest radiography were negative. MRI with contrast showed chronic lacunar infarcts in the periventricular white matter and absence of the left internal carotid artery (ICA) flow void likely due to occlusion. The right optic nerve was atrophic with increased T2 signal. CTA with contrast showed chronic occlusion of the left ICA, right posterior cerebral artery, right middle cerebral artery and left anterior cerebral artery A2 segment with extensive collateralization. Severe narrowing of the proximal left ICA beginning 5 mm beyond the bifurcation was noted. A catheter cerebral angiogram confirmed MMD. Vascular neurology and neurosurgery were consulted. Aspirin 81 mg daily was started. Moyamoya angiopathy is rare, optic atrophy is an unconventional presentation and they can be associated with trisomy 21. Studies are warranted to better understand and treat this condition.

University of Jordan (JO), The University of Texas MD Anderson Cancer Center (US), Cornell University (US), Kettering General Hospital (GB), University of Iowa Hospitals and Clinics (US), Methodist Hospital (US), Weill Cornell Medicine (US), The University of Texas Medical Branch at Galveston (US), Bryan College (US)
Good health and well-being
Openalex Percentile: Top 65%
Moyamoya disease diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Optic atrophy due to Moya Moya disease in Trisomy 21 — Laila Noor, Susana d'Avila, et al. · (2024) | TGRS Research Map | TGRS